Cargando…

Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis

Fibulin-3, originally identified in senescent and Werner syndrome fibroblasts, has been implicated in cell morphology, growth, adhesion and motility. Fibulin-3 exhibits both antitumor and oncogenic activities towards human cancers; however, the role of Fibulin-3 in hepatocellular carcinoma (HCC) rem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Rongzhen, Zhang, Meifang, Liu, Lili, Lu, Shixun, Zhang, Chris Zhiyi, Yun, Jingping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731361/ https://www.ncbi.nlm.nih.gov/pubmed/23936443 http://dx.doi.org/10.1371/journal.pone.0070511

Ejemplares similares

Downregulation of Polo-Like Kinase 4 in Hepatocellular Carcinoma Associates with Poor Prognosis
por: Liu, Lili, et al.
Publicado: (2012)

Low SIRT3 Expression Correlates with Poor Differentiation and Unfavorable Prognosis in Primary Hepatocellular Carcinoma
por: Zhang, Chris Zhiyi, et al.
Publicado: (2012)

Fibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomas
por: Chen, Jie, et al.
Publicado: (2015)

Increased expression of hepatocyte nuclear factor 4 alpha transcribed by promoter 2 indicates a poor prognosis in hepatocellular carcinoma
por: Cai, Shao-hang, et al.
Publicado: (2017)

Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma
por: Zhang, Xinyuan, et al.
Publicado: (2017)

Decrease of RBM4 indicates poor prognosis in patients with hepatocellular carcinoma after hepatectomy
por: Chen, Jian-yao, et al.
Publicado: (2017)

Fibulin-2 Facilitates Malignant Progression of Hepatocellular Carcinoma
por: Hu, Xinyan, et al.
Publicado: (2023)

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma()()
por: Fu, Jia, et al.
Publicado: (2015)

Decreased expression of zinc-alpha2-glycoprotein in hepatocellular carcinoma associates with poor prognosis
por: Huang, Yan, et al.
Publicado: (2012)

Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma
por: Wu, Yanqin, et al.
Publicado: (2016)

MMP16 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma
por: Shen, Zhenghai, et al.
Publicado: (2017)

High expression levels of CLEC4M indicate poor prognosis in patients with hepatocellular carcinoma
por: Luo, Liuping, et al.
Publicado: (2020)

Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma
por: Xia, Hai-Bing, et al.
Publicado: (2018)

Decreased expression of ApoF associates with poor prognosis in human hepatocellular carcinoma
por: Wang, Ya-Bin, et al.
Publicado: (2019)

Positive expression of ZNF689 indicates poor prognosis of hepatocellular carcinoma
por: Yi, Peng Sheng, et al.
Publicado: (2018)

Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma
por: Wang, Ying, et al.
Publicado: (2015)

CHCHD2 promotes hepatocellular carcinoma and indicates poor prognosis of hepatocellular carcinoma patients
por: Yao, Yang, et al.
Publicado: (2019)

Decreased DC-SIGNR expression in hepatocellular carcinoma predicts poor patient prognosis
por: Xia, Hai-Bing, et al.
Publicado: (2020)

Low expression of centrosomal protein 78 (CEP78) is associated with poor prognosis of colorectal cancer patients
por: Zhang, Meifang, et al.
Publicado: (2016)

LCMT1 indicates poor prognosis and is essential for cell proliferation in hepatocellular carcinoma
por: Zhang, Ning, et al.
Publicado: (2022)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
por: Lei, Xiong, et al.
Publicado: (2015)

eEF1A1 Overexpression Enhances Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma
por: Chen, Shi-Lu, et al.
Publicado: (2017)

Oncogenic Fibulin-5 Promotes Nasopharyngeal Carcinoma Cell Metastasis through the FLJ10540/AKT Pathway and Correlates with Poor Prognosis
por: Hwang, Chung-Feng, et al.
Publicado: (2013)

High USP22 expression indicates poor prognosis in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2015)

Linc00511 Indicates A Poor Prognosis Of Liver Hepatocellular Carcinoma
por: Hu, Pingan, et al.
Publicado: (2019)

Increased expression of G9A contributes to carcinogenesis and indicates poor prognosis in hepatocellular carcinoma
por: Qin, Jian, et al.
Publicado: (2018)

Decreased Expression of TMEM173 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Bu, Yang, et al.
Publicado: (2016)

Retraction: Oncogenic Fibulin-5 Promotes Nasopharyngeal Carcinoma Cell Metastasis through the FLJ10540/AKT Pathway and Correlates with Poor Prognosis
Publicado: (2020)

Increased Expression of Fibulin-1 Is Associated With Hepatocellular Carcinoma Progression by Regulating the Notch Signaling Pathway
por: Gong, Jiao, et al.
Publicado: (2020)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma
por: He, Fei, et al.
Publicado: (2015)

HBx‐mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis
por: Chen, Shi‐Lu, et al.
Publicado: (2017)

Alternatively activated NUSAP1 promotes tumor growth and indicates poor prognosis in hepatocellular carcinoma
por: Shi, Chao, et al.
Publicado: (2019)

Decreased expression of serum semaphorin 3B is associated with poor prognosis of patients with hepatocellular carcinoma
por: Li, Guang-Zhen, et al.
Publicado: (2021)

Co-expression of Piwil2/Piwil4 in nucleus indicates poor prognosis of hepatocellular carcinoma
por: Zeng, Guangping, et al.
Publicado: (2016)

PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis
por: Du, Peng, et al.
Publicado: (2021)

The expression of Fibulin-3 in ovarian cancer and its relationship with prognosis
por: Wang, Xinmei, et al.
Publicado: (2020)

Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma
por: Zhang, Jie, et al.
Publicado: (2019)

Roles of Fibulin-2 in Carcinogenesis
por: Zhang, Huayue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f7utn6dt4nc7obvr55u1sgq5pc